跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
modified cholera toxin
首页
药物
modified cholera toxin
modified cholera toxin
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
BIFUNCTIONAL CpG OR OLIGO-/POLYNUCLEOTIDE AND TOXIN OR ENTEROTOXIN CONTAINING COMPOSITION
US 2010330101 A1
申请人: DUOTOL AB
优先权: 2003
CN
US
2 件公开
Recombinant DNA, plasmid, transformed microorganism and vaccine protein for prevention and therapy of urinary tract infection
US 7001744 B2
申请人: UNIV SUNGKYUNKWAN
优先权: 2004
US
2 件公开
ORAL VACCINES PRODUCED AND ADMINISTERED USING EDIBLE MICRO-ORGANISMS INCLUDING LACTIC ACID BACTERIAL STRAINS
US 2013004547 A1
申请人: VAXGENE CORP
优先权: 2012
US
Targeting delivery system mediated by cholera toxin subunit B protein
CN 109248328 A
申请人: UNIV FUDAN
优先权: 2017
CN
Preparation method of ferroferric oxide and cholera toxin B subunit coupling and application thereof
CN 113663090 A
申请人: UNIV GUANGDONG TECHNOLOGY
优先权: 2021
CN
Composition for regulating production of fusion proteins
US 12331323 B1
申请人: ERAD THERAPEUTICS CANADA INC
优先权: 2024
US
药物
反馈